InsidersTradesSigma
AlzeCure Pharma AB Stock: price and directors' dealings · Finland · FIN-FSA
Track the AlzeCure Pharma AB share price and the full management transaction log of the company, a publicly traded company based in Finland. Shares are quoted on FI FI, under the oversight of FIN-FSA. Operating in the Health Care sector, AlzeCure Pharma AB has recorded 5 public disclosures. Market capitalisation: €1bn. The latest transaction was disclosed on 4 July 2026 (Purchase). Among the most active insiders: Martin Jönsson. All data is openly available.
5
Insider Decl.
0
Thresholds
€91,346
5 ops.
Buy Volume
·
0 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate AlzeCure Pharma AB Strong Buy (bullish), based on 1 analysts. Average price target: SEK 8.80.
47Σ signal
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 4 July 2026
Declarations5 total
184,914 shares@ SEK 1.310.027% mcap93.2% of flowBTA (betald tecknad aktie)FI:csv-cd6e11af1a52c2985dd2
Ideal exit: 29 Mar 2027 (T+270)
●
Annan medlem i bolagets administrations-, lednings- eller kontrollorganExecutives
177,275 shares@ SEK 1.310.0044% mcap100.0% of flowBTA (betald tecknad aktie)FI:csv-ece03a7e2fc9302981e3
Ideal exit: 23 Mar 2027 (T+270)
8,067 shares@ €0.19650.0010% mcap100.0% of flowAktieFI:A003R766-1
Ideal exit: 22 May 2026 (T+270)
150,000 shares@ €0.19630.018% mcap100.0% of flowBTA (betald tecknad aktie)FI:A003R169-1
Ideal exit: 20 Apr 2026 (T+270)
●
Annan medlem i bolagets administrations-, lednings- eller kontrollorganExecutives
20,000 shares@ SEK 8.97100.0% of flowAktieFI:A001P627-1
Ideal exit: 16 Oct 2021 (T+270)
5 of 5 declarations
About AlzeCure Pharma AB
AlzeCure Pharma AB is a biopharmaceutical company focused on developing treatments for neurodegenerative diseases. It is listed on the XSTO exchange.